Can MDMA Treat Traumatic Brain Injury? $1.5 Million Are Being Committed To Finding Out

Wesana Health (CSE: WESA) (OTCQB: WSNAF) and the Multidisciplinary Association for Psychedelic Studies (MAPS) are teaming up to analyze the effectiveness of MDMA-assisted therapy in the treatment of traumatic brain injury (TBI).

Wesana Health went public in May with a focus on developing psychedelic-assisted medicines and other therapies for victims of traumatic brain injury.

Wesana announced Monday that it has committed an initial $1.5 million to assess the viability of MDMA (also known colloquially as ecstasy or molly) of treating a subset of conditions resulting from TBI and that currently lack a cure or successful treatment, including chronic traumatic encephalopathy.

With the funding, MAPS will create a team to “evaluate the scope of …

Full story available on Benzinga.com

More Can MDMA Treat Traumatic Brain Injury? $1.5 Million Are Being Committed To Finding Out